Total Payments
$4,086
2024 Payments
$841.59
Companies
29
Transactions
199
Medicare Patients
2,880
Medicare Billing
$313,422
Payment Breakdown by Category
Food & Beverage$4,054 (99.2%)
Education$31.84 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,054 | 196 | 99.2% |
| Education | $31.84 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $955.58 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $472.57 | 20 | $0 (2024) |
| Amgen Inc. | $346.38 | 18 | $0 (2024) |
| Celgene Corporation | $326.52 | 11 | $0 (2019) |
| UCB, Inc. | $232.93 | 8 | $0 (2024) |
| MAYNE PHARMA INC. | $202.85 | 10 | $0 (2022) |
| Lilly USA, LLC | $187.41 | 8 | $0 (2023) |
| Aqua Pharmaceuticals | $165.85 | 15 | $0 (2017) |
| UROVANT SCIENCES INC | $124.16 | 1 | $0 (2022) |
| Galderma Laboratories, L.P. | $119.96 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $841.59 | 40 | ABBVIE INC. ($291.58) |
| 2023 | $490.40 | 22 | ABBVIE INC. ($85.48) |
| 2022 | $383.58 | 13 | ABBVIE INC. ($141.44) |
| 2021 | $195.87 | 8 | Amgen Inc. ($169.16) |
| 2020 | $70.30 | 3 | AbbVie Inc. ($40.88) |
| 2019 | $294.81 | 16 | AbbVie, Inc. ($114.53) |
| 2018 | $732.82 | 41 | Mayne Pharma Inc. ($177.74) |
| 2017 | $1,076 | 56 | Novartis Pharmaceuticals Corporation ($219.38) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Immunology | ||||||
| 07/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 07/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Immunology | ||||||
| 06/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 726 | 1,244 | $269,230 | $85,712 |
| 2022 | 16 | 746 | 1,204 | $239,126 | $80,407 |
| 2021 | 17 | 767 | 1,296 | $218,446 | $87,872 |
| 2020 | 14 | 641 | 1,075 | $169,970 | $59,430 |
Total Patients
2,880
Total Services
4,819
Medicare Billing
$313,422
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 294 | $58,800 | $19,953 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 170 | $66,183 | $16,055 | 24.3% |
| 11400 | Removal of noncancer skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 61 | 166 | $37,184 | $12,633 | 34.0% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 32 | 43 | $17,630 | $8,854 | 50.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 90 | 126 | $13,860 | $5,415 | 39.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 77 | $15,400 | $5,396 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $11,850 | $4,051 | 34.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 27 | 30 | $7,612 | $2,507 | 32.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 26 | 33 | $8,250 | $2,272 | 27.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 30 | 47 | $6,815 | $2,097 | 30.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 31 | 47 | $5,115 | $1,982 | 38.7% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 29 | $8,555 | $1,922 | 22.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 19 | 19 | $3,800 | $1,026 | 27.0% |
| 11420 | Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | Office | 2023 | 11 | 13 | $3,276 | $1,018 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 15 | 100 | $4,900 | $530.57 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 275 | $55,000 | $18,787 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 146 | $44,147 | $13,837 | 31.3% |
| 11400 | Removal of noncancer skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 48 | 123 | $27,552 | $10,063 | 36.5% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2022 | 29 | 34 | $13,940 | $6,956 | 49.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 78 | 101 | $20,200 | $6,440 | 31.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 85 | 114 | $12,540 | $5,008 | 39.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $11,613 | $3,783 | 32.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 31 | 42 | $10,500 | $3,424 | 32.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 26 | 30 | $7,612 | $3,176 | 41.7% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 24 | 30 | $8,850 | $2,041 | 23.1% |
About Dr. Belmina Michael, M.D
Dr. Belmina Michael, M.D is a Dermatology healthcare provider based in Forest Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063451458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Belmina Michael, M.D has received a total of $4,086 in payments from pharmaceutical and medical device companies, with $841.59 received in 2024. These payments were reported across 199 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,054).
As a Medicare-enrolled provider, Michael has provided services to 2,880 Medicare beneficiaries, totaling 4,819 services with total Medicare billing of $313,422. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Forest Park, IL
- Active Since 06/04/2006
- Last Updated 07/31/2009
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1063451458
Products in Payments
- SKYRIZI (Biological) $433.63
- Otezla (Drug) $430.69
- COSENTYX (Biological) $381.07
- Humira (Biological) $308.00
- Bimzelx (Biological) $232.93
- DORYX (Drug) $177.74
- TALTZ (Drug) $131.37
- GEMTESA (Drug) $124.16
- ADBRY (Biological) $112.64
- EUCRISA (Drug) $101.79
- Veltin (Drug) $99.40
- HUMIRA (Biological) $88.91
- ILUMYA (Biological) $82.89
- Enbrel (Biological) $78.37
- EPIDUO FORTE (Drug) $74.87
- COSENTYX (Drug) $74.34
- LIBTAYO (Biological) $74.07
- OLUMIANT (Drug) $56.04
- QUINJA (Drug) $55.95
- DUPIXENT (Drug) $49.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.